The new tripod ligands bis(pyrazolyl)(3-tert-butyl-2-thioimidazol-1-yl)hydroborate (L(1)) and bis(pyrazolyl)(3-isopropyl-2-thioimidazol-1-yl)hydroborate (L(2)), together with zinc nitrate or zinc chloride and the corresponding thiolates, have yielded a total of 17 zinc-thiolate complexes. These comprise aliphatic as well as aromatic thiolates and a cysteine derivative. Structure determinations have confirmed the tetrahedral ZnN(2)S(2) coordination in the complexes. Upon reaction with methyl iodide, the species L(1).Zn-SR are slowly converted to L(1).Zn-I and the free thioethers CH(3)SR. A kinetic analysis has shown these alkylations to be about 1 order of magnitude slower than those of the tris(pyrazolyl)borate complexes Tp(Ph,Me)Zn-SR. Alkylations with trimethyl phosphate were found to proceed very slowly even in DMSO at 80 degrees C.
The biologically relevant alkylations of the thiolate ligands in tripod zinc thiolates by methyl iodide were studied kinetically. Five tripod ligands of the pyrazolyl/thioimidazolyl borate type were employed, offering N3, N2S, NS2, and S3 donor sets. For each of them, the ethyl-, benzyl-, phenyl-, and p-nitrophenylthiolate zinc complexes were investigated, yielding a total of 20 second-order rate constants. The comparison of these rate constants shows three effects: (1) the electronic effect among the thiolates, i.e., the ethanethiolates react about 3 orders of magnitude faster than the p-nitrophenylthiolates; (2) the steric effect among the pyrazolylborates, i.e., the phenyl-substituted ones react about 2 orders of magnitude faster than the tert-butyl-substituted ones; and (3) the strong acceleration by the sulfur donors in the tripods, reaching 4 orders of magnitude between the reaction times of the (N3)Zn-SR and (S3)Zn-SR complexes.
The NS 2 ZnX coordination in thiolate-alkylating zinc enzymes is reproduced in (tripod)ZnX complexes with substituted pyrazolylbis(thioimidazolyl)borate tripod ligands. Intermediate (tripod)Zn nitrates and perchlorates are converted into (tripod)Zn thiolates, including the biologically relevant homocysteinate. Methylation with CH 3 I converts these to (tripod)ZnI and the corresponding thioethers CH 3 SR, including methionine. A kinetic investigation has shown the alky-
The anionic bis(pyrazolyl)(thioimidazolyl)borate ligands BpMt(R) with R = tert-butyl and isopropyl were obtained as their potassium salts by reacting potassium tris(pyrazolyl)borate with the corresponding thioimidazoles in the melt at 150 degrees C. They were applied to form some tetrahedral zinc complexes and identified by the crystal structures of (BpMt(t-Bu))ZnCl and (BpMt(i-Pr))Zn-SC(6)H(4)-p-Cl.
To answer the question as to whether gallium in its oxidation state +1 favors a σ‐ or a π‐coordination of aromatic nitrogen bases, we reacted [Ga(C6H5F)2]+[Al(ORF)4]– {RF = C(CF3)} with pyrazine and 2,6‐di‐tert‐butyl‐4‐methylpyridine (DTBMP). In doing so, we obtained the first tricoordinate, nonchelated, homoleptic N‐donor complex of gallium(I): [Ga(pyrazine)3]+[Al(ORF)4]–, in which each gallium(I) cation is coordinated in a trigonal‐pyramidal fashion by three η1‐donating pyrazine ligands. Hence, the gallium(I) cations favor σ‐ over π‐coordination. Depending on the reaction conditions, and due to the bifunctionality of pyrazine, 1D coordination polymers of {[Ga(μ‐pyrazine)2(η1‐pyrazine)]+[Al(ORF)4]–}∞ were also obtained. With the sterically demanding DTBMP, which is conventionally used as a proton scavenger, the mixed complex [Ga(C6H5F)2(DTBMP)]+[Al(ORF)4]– was isolated, thus proving incorrect the perception of DTBMP being “non‐nucleophilic”. The structural findings were confirmed by multinuclear NMR investigations and density functional performed at the RI‐BP86/SV(P) level.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.